Table of Content

1 Neurotrophins Market Overview
1.1 Product Overview and Scope of Neurotrophins
1.2 Neurotrophins Segment by Type
1.2.1 Global Neurotrophins Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Neurotrophins Segment by Application
1.3.1 Neurotrophins Sales Comparison by Application: (2021-2027)
1.3.2 Alzheimer'S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson'S Disease
1.3.5 Other
1.4 Global Neurotrophins Market Size Estimates and Forecasts
1.4.1 Global Neurotrophins Revenue 2016-2027
1.4.2 Global Neurotrophins Sales 2016-2027
1.4.3 Neurotrophins Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neurotrophins Market Competition by Manufacturers
2.1 Global Neurotrophins Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neurotrophins Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neurotrophins Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neurotrophins Manufacturing Sites, Area Served, Product Type
2.5 Neurotrophins Market Competitive Situation and Trends
2.5.1 Neurotrophins Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neurotrophins Players Market Share by Revenue
2.5.3 Global Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neurotrophins Retrospective Market Scenario by Region
3.1 Global Neurotrophins Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Neurotrophins Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Neurotrophins Market Facts & Figures by Country
3.3.1 North America Neurotrophins Sales by Country
3.3.2 North America Neurotrophins Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neurotrophins Market Facts & Figures by Country
3.4.1 Europe Neurotrophins Sales by Country
3.4.2 Europe Neurotrophins Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neurotrophins Market Facts & Figures by Region
3.5.1 Asia Pacific Neurotrophins Sales by Region
3.5.2 Asia Pacific Neurotrophins Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neurotrophins Market Facts & Figures by Country
3.6.1 Latin America Neurotrophins Sales by Country
3.6.2 Latin America Neurotrophins Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neurotrophins Market Facts & Figures by Country
3.7.1 Middle East and Africa Neurotrophins Sales by Country
3.7.2 Middle East and Africa Neurotrophins Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Neurotrophins Historic Market Analysis by Type
4.1 Global Neurotrophins Sales Market Share by Type (2016-2021)
4.2 Global Neurotrophins Revenue Market Share by Type (2016-2021)
4.3 Global Neurotrophins Price by Type (2016-2021)

5 Global Neurotrophins Historic Market Analysis by Application
5.1 Global Neurotrophins Sales Market Share by Application (2016-2021)
5.2 Global Neurotrophins Revenue Market Share by Application (2016-2021)
5.3 Global Neurotrophins Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Johnson＆Johnson
6.1.1 Johnson＆Johnson Corporation Information
6.1.2 Johnson＆Johnson Description and Business Overview
6.1.3 Johnson＆Johnson Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson＆Johnson Product Portfolio
6.1.5 Johnson＆Johnson Recent Developments/Updates
6.2 Lonza Groups
6.2.1 Lonza Groups Corporation Information
6.2.2 Lonza Groups Description and Business Overview
6.2.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Lonza Groups Product Portfolio
6.2.5 Lonza Groups Recent Developments/Updates
6.3 FibroGen
6.3.1 FibroGen Corporation Information
6.3.2 FibroGen Description and Business Overview
6.3.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.3.4 FibroGen Product Portfolio
6.3.5 FibroGen Recent Developments/Updates
6.4 Scil Proteins GmbH
6.4.1 Scil Proteins GmbH Corporation Information
6.4.2 Scil Proteins GmbH Description and Business Overview
6.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Scil Proteins GmbH Product Portfolio
6.4.5 Scil Proteins GmbH Recent Developments/Updates
6.5 Merck Serono
6.5.1 Merck Serono Corporation Information
6.5.2 Merck Serono Description and Business Overview
6.5.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck Serono Product Portfolio
6.5.5 Merck Serono Recent Developments/Updates
6.6 Scil Proteins GmbH
6.6.1 Scil Proteins GmbH Corporation Information
6.6.2 Scil Proteins GmbH Description and Business Overview
6.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Scil Proteins GmbH Product Portfolio
6.6.5 Scil Proteins GmbH Recent Developments/Updates
6.7 PeproTech
6.6.1 PeproTech Corporation Information
6.6.2 PeproTech Description and Business Overview
6.6.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.4.4 PeproTech Product Portfolio
6.7.5 PeproTech Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2016-2021)
6.8.4 GE Healthcare Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates

7 Neurotrophins Manufacturing Cost Analysis
7.1 Neurotrophins Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neurotrophins
7.4 Neurotrophins Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neurotrophins Distributors List
8.3 Neurotrophins Customers

9 Neurotrophins Market Dynamics
9.1 Neurotrophins Industry Trends
9.2 Neurotrophins Growth Drivers
9.3 Neurotrophins Market Challenges
9.4 Neurotrophins Market Restraints

10 Global Market Forecast
10.1 Neurotrophins Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neurotrophins by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neurotrophins by Type (2022-2027)
10.2 Neurotrophins Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neurotrophins by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neurotrophins by Application (2022-2027)
10.3 Neurotrophins Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neurotrophins by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neurotrophins by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurotrophins Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neurotrophins Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Neurotrophins Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neurotrophins Covered in This Study
Table 5. Global Neurotrophins Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Neurotrophins Sales Share by Manufacturers (2016-2021)
Table 7. Global Neurotrophins Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neurotrophins Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neurotrophins Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neurotrophins Manufacturing Sites and Area Served
Table 11. Manufacturers Neurotrophins Product Type
Table 12. Global Neurotrophins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neurotrophins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophins as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neurotrophins Sales by Region (2016-2021) & (K Units)
Table 16. Global Neurotrophins Sales Market Share by Region (2016-2021)
Table 17. Global Neurotrophins Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neurotrophins Sales by Country (2016-2021) & (K Units)
Table 19. North America Neurotrophins Sales Market Share by Country (2016-2021)
Table 20. North America Neurotrophins Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neurotrophins Revenue Market Share by Country (2016-2021)
Table 22. Europe Neurotrophins Sales by Country (2016-2021) & (K Units)
Table 23. Europe Neurotrophins Sales Market Share by Country (2016-2021)
Table 24. Europe Neurotrophins Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neurotrophins Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neurotrophins Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Neurotrophins Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neurotrophins Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neurotrophins Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neurotrophins Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Neurotrophins Sales Market Share by Country (2016-2021)
Table 32. Latin America Neurotrophins Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neurotrophins Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neurotrophins Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Neurotrophins Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neurotrophins Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neurotrophins Revenue Market Share by Country (2016-2021)
Table 38. Global Neurotrophins Sales (K Units) by Type (2016-2021)
Table 39. Global Neurotrophins Sales Market Share by Type (2016-2021)
Table 40. Global Neurotrophins Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neurotrophins Revenue Share by Type (2016-2021)
Table 42. Global Neurotrophins Price (US$/Unit) by Type (2016-2021)
Table 43. Global Neurotrophins Sales (K Units) by Application (2016-2021)
Table 44. Global Neurotrophins Sales Market Share by Application (2016-2021)
Table 45. Global Neurotrophins Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neurotrophins Revenue Share by Application (2016-2021)
Table 47. Global Neurotrophins Price (US$/Unit) by Application (2016-2021)
Table 48. Johnson＆Johnson Corporation Information
Table 49. Johnson＆Johnson Description and Business Overview
Table 50. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Johnson＆Johnson Neurotrophins Product
Table 52. Johnson＆Johnson Recent Developments/Updates
Table 53. Lonza Groups Corporation Information
Table 54. Lonza Groups Description and Business Overview
Table 55. Lonza Groups Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Lonza Groups Neurotrophins Product
Table 57. Lonza Groups Recent Developments/Updates
Table 58. FibroGen Corporation Information
Table 59. FibroGen Description and Business Overview
Table 60. FibroGen Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. FibroGen Neurotrophins Product
Table 62. FibroGen Recent Developments/Updates
Table 63. Scil Proteins GmbH Corporation Information
Table 64. Scil Proteins GmbH Description and Business Overview
Table 65. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Scil Proteins GmbH Neurotrophins Product
Table 67. Scil Proteins GmbH Recent Developments/Updates
Table 68. Merck Serono Corporation Information
Table 69. Merck Serono Description and Business Overview
Table 70. Merck Serono Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Merck Serono Neurotrophins Product
Table 72. Merck Serono Recent Developments/Updates
Table 73. Scil Proteins GmbH Corporation Information
Table 74. Scil Proteins GmbH Description and Business Overview
Table 75. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Scil Proteins GmbH Neurotrophins Product
Table 77. Scil Proteins GmbH Recent Developments/Updates
Table 78. PeproTech Corporation Information
Table 79. PeproTech Description and Business Overview
Table 80. PeproTech Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. PeproTech Neurotrophins Product
Table 82. PeproTech Recent Developments/Updates
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. GE Healthcare Neurotrophins Product
Table 87. GE Healthcare Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Neurotrophins Distributors List
Table 91. Neurotrophins Customers List
Table 92. Neurotrophins Market Trends
Table 93. Neurotrophins Growth Drivers
Table 94. Neurotrophins Market Restraints
Table 95. Global Neurotrophins Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Neurotrophins Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Neurotrophins Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Neurotrophins Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Neurotrophins Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Neurotrophins Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Neurotrophins Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Neurotrophins Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Neurotrophins Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Neurotrophins Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Neurotrophins Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Neurotrophins Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurotrophins
Figure 2. Global Neurotrophins Market Share by Type in 2020 & 2027
Figure 3. Nerve Growth Factor Product Picture
Figure 4. Brain-Derived Neurotrophic Factor Product Picture
Figure 5. Dehydroepiandrosterone Sulfate Product Picture
Figure 6. Other Product Picture
Figure 7. Global Neurotrophins Market Share by Application in 2020 & 2027
Figure 8. Alzheimer'S Disease
Figure 9. Amyotrophic Lateral Sclerosis
Figure 10. Parkinson'S Disease
Figure 11. Other
Figure 12. Global Neurotrophins Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Neurotrophins Market Size 2016-2027 (US$ Million)
Figure 14. Global Neurotrophins Sales 2016-2027 (K Units)
Figure 15. Global Neurotrophins Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Neurotrophins Sales Share by Manufacturers in 2020
Figure 17. Global Neurotrophins Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Neurotrophins Players: Market Share by Revenue in 2020
Figure 19. Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Neurotrophins Sales Market Share by Region (2016-2021)
Figure 21. Global Neurotrophins Sales Market Share by Region in 2020
Figure 22. Global Neurotrophins Revenue Market Share by Region (2016-2021)
Figure 23. Global Neurotrophins Revenue Market Share by Region in 2020
Figure 24. U.S. Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Neurotrophins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Neurotrophins by Type (2016-2021)
Figure 49. Sales Market Share of Neurotrophins by Application (2016-2021)
Figure 50. Sales Market Share of Neurotrophins by Application in 2020
Figure 51. Revenue Share of Neurotrophins by Application (2016-2021)
Figure 52. Revenue Share of Neurotrophins by Application in 2020
Figure 53. Manufacturing Cost Structure of Neurotrophins
Figure 54. Manufacturing Process Analysis of Neurotrophins
Figure 55. Neurotrophins Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed